Rifampicin is a potent inducer of:
A. CYP3A4
B. CYP2C9
C. CYP2D6
D. CYP1A2
According to GCP, informed consent must be obtained:
A. After study initiation
B. Before any study-specific procedures
C. Only after first dose
D. Only if patient requests
Pharmanews Limited is a health care publishing, training and consultancy firm, positioned to ensure consistent improvements in the quality of pharmaceutical and health care services through publishing and training.
© 2025 Pharmanews Limited. All rights reserved.
A
B
A
B
A
B
A
B
1 A
2 B
1 A
2 B
1 A
2 B
A
B